Navigation Links
Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
Date:10/23/2007

ooking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the U.K. combination REOLYSIN(R)/cyclophosphamide clinical trial, and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the tolerability of REOLYSIN(R) outside a controlled test, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., , IRVINE, Calif., Dec. 4 /PRNewswire-Fir...tin Board: BFRE), a company focused on changing th... production of ethanol from non-food cellulosic wa...igest list of the "50 Hottest Companies in Bioene... top 20. ,, "Having voters rank BlueFire Ethan...
(Date:12/3/2009)..., , PHILADELPHIA, Dec. 3 /PRNewswire-FirstC... global specialty biopharmaceutical company, today...untary market withdrawal of one lot of the Attenti...trana ® . Shire is taking this action because...e may not meet their release liner removal specifi...
(Date:12/2/2009)..., , COLUMBIA, Md., Dec. 2 /PRNewswire-Firs... MATK ) announced today that it intends to release... 2009 on December 16, 2009, at approximately 4:00 ... 4:45 p.m. ET Martek will conduct a conference cal...terested parties may listen to the call live via w...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire-USNewswire...tists, policy makers, and funders today convened t...ive funding strategies at the inaugural Partnerin...shington-based center of the Milken Institute, con...ector collaborations needed to turn a scientific d...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
...d today a,major new release of its IDEAS(R) statis...ncorporates greatly expanded analytical capabiliti... IDEAS 3.0 provides the user with dozens of new im...tures to strengthen morphological,data analysis. T...reater,flexibility in defining specific areas of i...
...tific Inc. (NYSE: TMO ) announced that it will re...of 2008 before the market opens on Thursday,April ...ame day at 9:00,a.m. Eastern Time., During the ca...ancial,performance as well as future expectations.... (703) 639-1307 outside the U.S. and use conferenc...
...s year,s,Venture Forum to the life sciences indust...ounced a partnership in developing and producing t...owcase the most promising and,innovative seed and ...and,around the globe. The 2008 Life Sciences Ventu...anta Clara Convention Center and will provide vent...
Other Biology Technology:Amnis Announces Release of Powerful New Image Data Analysis Software 2Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 24, 2008 2Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum 2Larta Institute Partners With Burrill & Company to Present the 14th Annual Life Sciences Venture Forum 3
(Date:12/3/2009)...ost scientists believe that staph infections are c...er to emit toxins. The signaling process is called...ent to start the process. , But the Jeff Brinker... stage of staph infection, when bacteria switch fr...le cell and that this individual process can be st...
(Date:12/3/2009)...dergo a personality change in warmer water, accord...mate change may make some species more aggressive....ish on Australia,s Great Barrier Reef have shown f...onsistently timid, or consistently bold, and that ...as water temperatures rise. , A slight lift of j...
(Date:12/3/2009)...e included in the design of the upcoming forest de...crisis, according to a scientist at the University...n Lewis argues that at least 50% of the carbon cre...REDD (Reducing Emissions from Deforestation and De...ctly, and their property rights assured. , "Ther...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Fish with attitude: Some like it hot 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Dr Chugay 28drchugay com 29 Revolutionary Weight Loss Surgery 52165 1Dr Chugay 28drchugay com 29 Revolutionary Weight Loss Surgery 52165 2NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 1NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 2NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 3NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 4NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 5NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 6Genetic Variation Associated With Survival Advantage in African Americans With HIV 52161 1Genetic Variation Associated With Survival Advantage in African Americans With HIV 52161 2Genetic Variation Associated With Survival Advantage in African Americans With HIV 52161 3Genetic Variation Associated With Survival Advantage in African Americans With HIV 52161 4
...nternational group of scientists has announced a m... the activities of genes in living organisms. The...to describe the complex events that occur when a p...t. Understanding these events is crucial for devel...by disease-causing microbes while preserving or en...
...thematician at the University of York has been awa...,000 by the Leverhulme Trust to study the geometry...eader in the Departments of Biology and Mathematic...s, which will help to develop new anti-viral strat...nal shells formed from proteins that encapsulate t...
...archers have long said they won,t be able to under...ing diagram" ?a map of how billions of neurons are...itute for Biological Studies have jumped what many...art: identifying all of the connections to a singl...uron, the researchers describe how they modified t...
Other Biology News:Uniform language for describing genes of pathogenic and beneficial microbes 2Uniform language for describing genes of pathogenic and beneficial microbes 3York mathematician probes geometric route to combat viruses 2Deconstructing brain wiring, one neuron at a time 2Deconstructing brain wiring, one neuron at a time 3
F10 Tubing Kit from Bio-Rad
PTC-100 cycler with gold/silver block from Bio-Rad
SUPER SENSITIVE READY-TO-USE MULTILINK IHC DETECTION KIT, HORSE RADISH PEROXIDASE/AEC, FOR AUTOMATION from BioGenex
IHC KIT FOR RAT ANTIBODIES ON MOUSE TISSUE, DAB KIT from BioGenex
Biology Products: